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Background: Previous studies associate lipid peroxidation with long-term memory (LTM) failure in a gastropod
model (Lymnaea stagnalis) of associative learning and memory. This process involves activation of Phospholipase A2
(PLA2), an enzyme mediating the release of fatty acids such as arachidonic acid that form the precursor for a variety
of pro-inflammatory lipid metabolites. This study investigated the effect of biologically realistic challenges of
L. stagnalis host defense response system on LTM function and potential involvement of PLA2, COX and LOX therein.
Results: Systemic immune challenges by means of β-glucan laminarin injections induced elevated H2O2 release
from L. stagnalis circulatory immune cells within 3 hrs of treatment. This effect dissipated within 24 hrs after
treatment. Laminarin exposure has no direct effect on neuronal activity. Laminarin injections disrupted LTM
formation if training followed within 1 hr after injection but had no behavioural impact if training started 24 hrs
after treatment. Intermediate term memory was not affected by laminarin injection. Chemosensory and motor
functions underpinning the feeding response involved in this learning model were not affected by laminarin
injection. Laminarin’s suppression of LTM induction was reversed by treatment with aristolochic acid, a PLA2
inhibitor, or indomethacin, a putative COX inhibitor, but not by treatment with nordihydro-guaiaretic acid, a
putative LOX inhibitor.
Conclusions: A systemic immune challenge administered shortly before behavioural training impairs associative
LTM function in our model that can be countered with putative inhibitors of PLA2 and COX, but not LOX. As such,
this study establishes a mechanistic link between the state of activity of this gastropod’s innate immune system and
higher order nervous system function. Our findings underwrite the rapidly expanding view of neuroinflammatory
processes as a fundamental, evolutionary conserved cause of cognitive and other nervous system disorders.
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The innate immune system is the first line of defense
against invading pathogens and other xenobiotic sub-
stances. Its activation is characterized by a host of cellu-
lar responses including the release of pro-inflammatory
compounds such as cytokines and the production of
high levels of reactive oxygen and nitrogen species (ROS
and RNS) [1-3]. While these compounds play critical
roles in the orchestration and execution of the host
defense response, their actions are not always limited to
the immune system. For instance, whereas various ROS
and pro-inflammatory agents play important roles in the
normal physiology of the brain, imbalances in these sig-
nalling systems have been associated with detrimental
effects on brain function [4,5]. Particularly, excessive
(experimentally) increased levels of ROS are associated
with decreased cognitive performance in both verte-
brates and invertebrates [5,6], leading to the suggestion
that reducing ROS levels in animals with elevated ROS
may be sufficient to improve memory function [6-8].
One of the major players in the execution of the in-
flammatory response recruited by ROS is Phospholipase
A2 (PLA2), a family of enzymes that mediate the release
of free fatty acids (FFA) from the sn-2 position of mem-
brane phospholipids [9-12]. One of the FFA’s liberated
by PLA2 is arachidonic acid, the primary substrate for
the epoxygenase (CYP-450), lipoxygenase (LOX) and the
cyclooxygenase (COX) branches of the eicosanoid path-
way. Together, COX, LOX and CYP-450 generate a
range of primarily inflammatory modulators [13-18]. Im-
portantly, ROS are also generated as a by-product of
COX activity, thus creating a positive feedback loop that
potentially can cause escalation of PLA2 and COX-
dependent aspects of the host defense response and sub-
stantive deregulation of lipid homeostasis [15,19].
Under normal physiological conditions, the potential
damage induced by ROS and other highly reactive oxi-
dizers is controlled by the antioxidant defense system,
an array of enzymatic and non-enzymatic elements
[15,19]. However, under certain conditions antioxidant
defense capacity of an organism may become over-
whelmed by either excessive formation of ROS and other
oxidizers, failing antioxidant capacity or both. Such im-
balance can lead to oxidative stress. For example, pro-
oxidative shifts in cellular redox status may arise as a
consequence of immune system recruitment. Interest-
ingly, age-associated accession of immune-derived oxi-
dative stress and its impact on phospholipid metabolism
are increasingly regarded as a factor in both biological
and pathological aging of the nervous system [6,9,20-25].
In view of the above and building on our recent
observations implicating age-associated and experimen-
tal oxidative-stress related induction of PLA2 activity in
learning and memory impairment [6] we investigatedthe question whether a biologically realistic experimental
provocation of the immune system also caused cognitive
impairment in our model system.
In our studies we use the pond snail Lymnaea
stagnalis (L. stagnalis) as a model system to delineate
the neurobiological intracies of oxidative-stress and
age-associated memory impairment [6,26,27]. In this
study we utilize an established and widely used classical
appetitive reward-conditioning paradigm involving che-
mosensory conditioning of L. stagnalis’ feeding behav-
iour (i.e., “rasping”) [26,28-32]. Using this model we
investigated the effects of experimental systemic chal-
lenges to the snails’ immune system on long term asso-
ciative memory (LTM) formation in the absence and
presence of PLA2, COX and LOX inhibitors.
As systemic immune challenge we delivered β-1,3 glu-
can laminarin intra-coelomic by means of injection. Pre-
vious work has shown that this β-glucan is a potent
stimulant of circulating haemocytes, the principal cellu-
lar effectors of L. stagnalis’ immune response [33-37].
The response repertoire of these cells includes elimin-
ation of pathogens via phagocytosis, encapsulation and
the generation of various reactive oxygen and nitrogen
intermediates (e.g., H2O2, NO) what is called the respira-
tory burst [35-39]. Our results implicate the state of acti-
vation of L. stagnalis host defense system to be a
contributing factor in the species’ appetitive learning
performance and indicate a pivotal role for PLA2 and
COX in the process of immune-associated suppression
of the species’ learning abilities.
Results
In vivo immune response to laminarin
To examine whether systemic delivery of a immune
stimulant triggers an immune response in animals, we first
performed experiments measuring haemocyte H2O2 re-
lease at varying times after intracoelomic injection of a
single bolus of laminarin (~5 mg/ml haemolymph concen-
tration) or vehicle-only. Haemocytes of both laminarin-
treated and vehicle control animals were collected 0.5, 1, 3
and 24 hrs after injection and immediately submitted to
fluorescent respiratory burst assays. Figure 1 shows that
Amplex-Red fluorescence was very similar in samples of
haemocytes collected from laminarin and vehicle treated
animals 0.5 hr, 1 hr and 24 hrs after injection, but signifi-
cantly differed in samples collected 3 hrs after injection
(Figure 1; ANOVA interaction time × treatment; F3,82 =
3.04, p < 0.05 planned comparison laminarin vs. vehicle at
0.5 hr F1,82 = 0.578, p = 0.45; 1 hr F1,82 = 0.549, p = 0.46;
3 hrs F1,82 = 8.177, p = 0.005; 24 hrs F1,82 = 0.027, p = 0.86).
Laminarin does not directly affect neuronal activity
Next, we examined whether laminarin application to the
nervous system directly affect neuronal activity of the



















Figure 1 Time dependent effect of laminarin induced release of
H2O2 by haemocytes. An increase in H2O2 production was
detected when animals received a bolus injection of laminarin 3 hrs
before hemocyte collection in comparison with their time corres-
ponding vehicle treated animals. Injection of laminarin 0.5 hr, 1 hr or
24 hrs before measurement failed to detect any differences in H2O2
release between the laminarin treated groups and their time corres-

























































Figure 2 No acute and direct effect of laminarin on neuronal
activity. A. Examples of intracellular recordings of CGCs before or
after 30 minutes exposure of the isolated CNS to vehicle (saline)
only (top trace) or laminarin (bottom trace). B. Average membrane
potential of the CGCs before or 30 minutes post-treatment in
vehicle only or laminarin exposed CNS. No significant difference was
observed between the two treatment groups. C. Relative action
potential frequency of CGCs 15 minutes before and during 30
minutes of exposure to laminarin or vehicle only. No significant
difference was observed between the two treatment groups.
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terneurons with a critical function in the expression of
appetitive LTM. CNSs were either exposed for 15 mi-
nutes to saline followed by a 30 min laminarin (5 mg/
ml) treatment or to saline only for the same period of
time while recording intracellular from the CGC. These
experiments revealed no significant differences in CGC
resting membrane potential and spontaneous action po-
tential activity between CNS subjected to the two test
conditions (Figure 2; ANOVA interaction time × treat-
ment; F1,9 = 0.26, p = 0.62 for resting membrane poten-
tial and F8,36 = 0.44, p = 0.89 for electrical activity).
Laminarin induced long term memory deficits
To assess laminarin’s impact on the formation of appeti-
tive long term memory (LTM) animals randomly
assigned to four test groups were injected with, respect-
ively, laminarin or vehicle-only either 1 or 24 hours
before their first training session and tested for the pres-
ence of conditioned feeding responses ~24 hrs after their
last training session (Figures 3A1 and 3B1). These exper-
iments revealed a prominent suppression of conditioned
feeding responses in animals that received treatment
with laminarin 1 hr prior to the first training session but
not in any of the other three test groups (c.f., Figures 3A2
and 3B2; ANOVA interaction training × treatment;
F1,126 = 7.475, p = 0.007 for animals trained 1 hr afterinjection and ANOVA interaction training × treatment;
F1,32 = 0.0093, p = 0.92 for animals trained 24 hrs after
injection). Notably, both vehicle-injected conditioned
test groups (CS-UCS) displayed robust conditioned feed-
ing responses compared to their non-conditioned peers
whether they were injected 1 hr or 24 hrs prior to their
training (F1,126 = 26.596 p < 0.0001 and F1,32 = 5.476
p = 0.03, respectively). In the case of laminarin-injected
animals statistically significant conditioned feeding re-
sponses were only observed in animals trained 24 hrs
after they received their injections (1 hr: F1,126 = 3.743
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Figure 3 Long-term memory assessments after laminarin
injection. A1. Protocol indicating timing of injection and start of
pre- and post training tests with respect to the start of the first
training session for both the conditioned (CS-UCS) and control
(CS-DS) animals. A2. LTM assessment in animals injected 1 hr before
training. There was a robust response to conditioning in vehicle
injected animals. In contrast, none of the unconditioned animals or
the laminarin treated conditioned animals responded with signifi-
cant feeding movements in the post-training test. These results
indicate LTM impairment in snails treated with laminarin 1 hr before
training. B1. Protocol indicating timing of injection and start of pre-
and post training tests with respect to the start of the first training
session for both the conditioned (CS-UCS) and control (CS-DS) animals.
B2. LTM assessment in animals treated 24 hrs before training. Both
laminarin and vehicle treated conditioned animals showed a significant
increase in the Δrasp values in the post-training test compared to their
unconditioned peers suggesting that laminarin has no adverse effect
on LTM performance when injected a day before training. * = P < 0.05,
*** = p < 0.001, ns = non-significant.
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conditioning in animals treated with laminarin 1 hr prior
to training the results leave no doubt (see Figure 3A2)
that, in contrast to the animals trained 24 hrs after treat-
ment, the impact of training in this group is drastically
reduced compared to their vehicle-injected counterparts
(F1,126 = 22.481, p < 0.0001 for animals trained 1 hr post-
treatment and F1,32 = 0.001, p = 0.98 for animals trained
24 hrs post-treatment).
Laminarin does not affect chemosensory or motor
functions
To assess the possibility that the behavioural results
presented above were due to effects of laminarin injec-
tion on chemosensory and/or motor proficiency rather
than plasticity mechanisms underlying appetitive LTM
formation, we performed a number of electrophysio-
logical and behavioural control tests.
First, we verified the amyl-acetate detection ability of
laminarin-treated animals through analysis of evoked
electrical responses recorded in the right superior lip
nerve (RSLN) of semi-intact preparations. The RSLN
carries chemosensory information from the lip area to
the CNS. Figures 4A and 4B show representative exam-
ples of extracellular recordings of the RSLN of animals
pre-treated 1 hr prior with vehicle-only and laminarin
injections. The figures illustrate that robust increases in
spiking frequency were recorded from the RSLN upon
application of 4 ppm amyl-acetate to the lip in both ex-
perimental groups. On average, spiking frequency rap-
idly climbed from a baseline of around 200 events per
30 seconds immediately preceding the sensory stimulus
to 300-400 events per 30 seconds during application of
the stimulus in both test groups (n = 8 for both groups).
Formal statistical analysis indicated a highly significant

















































Figure 4 Effect of laminarin injection on chemosensory and
motor function. A. Examples of extracellular recording of afferents
in the superior lip nerve before and after application of n-amyl
acetate (4 ppm) of animals injected one hour prior with vehicle only
(top trace) or laminarin (bottom trace). B. Average action potential
frequency (bin size 30 sec) of afferents in superior lip nerve 3
minutes before and 2 minutes during amyl acetate application.
There is no difference in response upon n-amyl acetate application
between the two different treatment groups C. Average change in
the number of rasps evoked by application of pond water (DS) or
sucrose (0.4%). Only sucrose induced a robust but similar response
in animals injected with vehicle or laminarin.
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of the test animals (ANOVA time vs. treatment F1,9 =
1.349, p = 0.22; laminarin amyl-acetate effect in laminarin
pre-treated preparations F1,14 = 60.87, p < 0.0001; amyl-
acetate effect in vehicle-only pre-treated preparations
F1,14 = 15.871, p < 0.001).
Behavioural assessment of the possibility that laminarin-
injection adversely affects feeding motor functions was
done by testing the unconditioned feeding response to su-
crose of intact animals pre-treated 1 hr prior with either
laminarin or vehicle-only. Figure 4C illustrates that there
were no meaningful differences in the response charac-
teristics of the two test groups. That is, the disturbance
stimulus (DS) did not elicit a significant response in
either of the test groups, whereas application of 0.4%
sucrose induced robust, statistically indistinguishable
feeding responses in animals injected with laminarin
(n = 8) and animals pre-treated with vehicle-only injec-
tions (n = 8; ANOVA interaction stimulus type × treat-
ment F1,14 = 2.12, p = 0.17; main effect stimulus type
F1,14 = 148.783, p < 0.0001; sucrose response in laminarin
vs. vehicle pretreated animals F1,14 = 0.979, p = 0.34).
Laminarin does not affect intermediate term memory
To test the possibility of a differential sensitivity of
appetitive intermediate term memory (ITM) and LTM to
systemic laminarin challenges, we examined ITM per-
formance of vehicle and laminarin treated snails 1-2 hrs
after the end of the last training trial (Figure 5A).
Figure 5B shows that laminarin treatment has no effect on
ITM formation (ANOVA interaction training × treatment;
F1,26 = 1.477, p = 0.24). That is, the conditioned animals
of each of the treatment groups responded signifi-
cantly different from their unconditioned partners
(vehicle: F1,26 = 16.64 p < 0.001; laminarin F1,26 =
4.628, p = 0.04). Conditioned vehicle and laminarin
treated animals showed similar feeding responses
(F1,26 = 1.425, p = 0.24).
Laminarin induced LTM deficiency involves PLA2
Considering PLA2’s pivotal role in the orchestration of
key facets of the inflammatory response in many model
systems, we next probed PLA2’s involvement in the lami-
narin induced LTM deficits presented above. To test this
idea, four groups of animals that received, respectively,
intracoelomic injections of either laminarin, aristolochic
acid, laminarin + aristolochic acid or vehicle-only were
behaviourally assessed as described before (Figure 6A).
The results of these experiments are summarized in
Figure 6B.
We found that pretreatment with the PLA2 inhibitor
aristolochic acid counteracted laminarin’s negative effect
on LTM formation (ANOVA training × laminarin-
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Figure 5 Intermediate-term memory assessments after
laminarin injection. A. Protocol indicating timing of injection
and start of pre- and post training tests with respect to the
start of the first training session for both the conditioned
(CS-UCS) and control (CS-DS) animals. B. ITM assessment in
animals treated 1 hr before training. Both laminarin and
vehicle treated conditioned animals showed a significant
increase in the Δrasp values in the post-training test compared
to their unconditioned peers suggesting that laminarin has no
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Figure 6 PLA2 inhibition restores LTM deficiency in laminarin
treated animals. A. Protocol indicating timing of injection and start
of pre- and post training tests with respect to the start of the first
training session for both the conditioned (CS-UCS) and control
(CS-DS) animals. B. LTM assessment in animals treated with either
vehicle, laminarin, aristolochic acid (aristo acid) or a combined
treatment of laminarin plus aristolochic acid (lamin + aristo acid). The
laminarin treated conditioned group, showed a significant reduction
in their Δrasp values in the post-training test compared to all other
conditioned groups. Animals treated with aristolochic acid only or
laminarin + aristolochic acid were not different in their conditioned
response than the vehicle treated animals. This suggests that
co-treatment of laminarin with a PLA2 inhibitor reverses the lamina-
rin induced adverse effect on LTM performance. * = p < 0.05,
*** p < 0.001, ns = not significant.
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this interaction resided in opposing effects of laminarin
and aristolochic acid on conditioned feeding responses.
That is, while pretreatment with laminarin caused a sig-
nificant reduction in the conditioned feeding response
compared to vehicle treated animals as before (c.f.,
Figure 3A2 & Figure 6B; F1,135 = 20.234, p < 0.0001), ani-
mals pretreated with aristolochic acid learned well
(F1,135 = 9.934, p = 0.002) in a manner that was statisti-
cally indistinguishable from that of vehicle pretreated
animals (Figure 6B c.f., white bars with dark-gray bars;
F1,135 = 2.351, p = 0.13). Moreover, animals pretreated
with the combination of laminarin and aristolochic acid
did display a significant conditioned feeding response
(Figure 6B black bars; F1,135 = 8.128, p = 0.005) that was
significantly different from the laminarin injected ani-
mals (Figure 6B c.f., light gray bars with black bars;
F1,135 = 4.937, p = 0.03).Laminarin induced LTM impairment is rescued by
indomethacin
Next, we tested the possibility of the involvement of the
eicosanoid pathway in the laminarin-induced LTM im-
pairment. For this purpose we used nordihydroguaiaretic
acid (NDGA) and indomethacin, broad-spectrum inhibi-
tors of, respectively, LOX and COX, the two major
branches of the eicosanoid pathway. Drug administra-
tion, training and 24 hrs LTM assessment were
performed according to procedures described before
(Figure 7A). Consistent with previous results, laminarin-
injected animals but not vehicle-injected animals failed
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Figure 7 Indomethacin restores LTM failure in laminarin
treated animals. A. Protocol indicating timing of injection and start
of pre- and post training tests with respect to the start of the first
training session for both the conditioned (CS-UCS) and control
(CS-DS) animals. B. LTM assessment in animals treated with either
vehicle, laminarin, indomethacin, a combined treatment of laminarin
plus indomethacin (lamin + indo) or a combined treatment of
laminarin plus NDGA (lamin + NDGA). None of the laminarin treated
conditioned animals and laminarin + NDGA conditioned animals or
any of the unconditioned animals responded with significant
feeding movements upon amyl acetate application in the post-
training test. Indomethacin only treated animals showed a
significant increase in their Δrasp values compared to their
unconditioned peers but this conditioned response was significantly
smaller than observed in the vehicle conditioned animals. Both
vehicle and laminarin + indomethacin treated conditioned animals
responded with a significant increase in the Δrasp values compared
to their unconditioned peers and the laminarin conditioned animals.
This suggests that co-treatment of laminarin with a COX inhibitor
reverses the laminarin induced adverse effect on LTM performance.
** = p < 0.01, *** p < 0.001, ns = not significant.
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white bars; ANOVA treatment x training F4,222 = 3.02,
p = 0.019, F1,222 = 23.522 p < 0.0001). The black bars in
Figure 7B show that concurrent treatment with lami-
narin and NDGA (~10 μM haemolymph concentration)
did not prevent LTM failure. In fact, the amyl-acetate
evoked rasping response of conditioned animals pretreated
with laminarin plus NDGA was indistinguishable from
their unconditioned (CS-DS) counterparts (F1,222 = 0.028p = 0.87). In contrast, the conditioned feeding response of
indomethacin treated animals (~10 μM haemolymph con-
centration) differed significantly from that of their none
conditioned counterparts (Figure 7B; contrast indo condi-
tioned vs unconditioned F1,222 = 4.499, p = 0.04). However,
as the figure illustrates the conditioned feeding response
of indomethacin treated animals was significantly attenu-
ated when compared with conditioned vehicle treated
animals (Figure 7B; contrast vehicle vs Indo F1,222 = 6.166,
p = 0.01). Interestingly, concurrent treatment with lami-
narin and indomethacin significantly improved conditioned
feeding responses of the trained animals. That is, in con-
trast to the animals treated with laminarin only, animals
that received laminarin plus indomethacin showed a robust
conditioned feeding response (F1,222 = 7.911 p = 0.005) that
was neither significantly different from the conditioned re-
sponse of animals treated with vehicle-only (F1,222 = 3.018
p = 0.09) nor from that of animals treated with indometh-
acin only (F1,222 = 0.656 p = 0.42).
Haemocyte activation is not affected by aristolochic acid
or indomethacin
The effects of aristolochic acid and indomethacin de-
scribed above may arise from inhibition of laminarin-
induced processes at the level of immunocytes or the
level of the nervous system. Thus next we explicitly
tested the former possibility by measuring the impact of
both compounds on laminarin induced H2O2 release by
isolated haemocytes. Amplex Red fluorescence was very
similar in laminarin activated haemocytes that were pre-
treated with either aristolochic acid or indomethacin
when compared to haemocytes pre-treated with vehicle-
only (Figure 8; ANOVA; F2,8 = 0.401, p = 0.69).
Discussion
The primary purpose of this study was to examine the
plausibility of inflammation-mediated learning and
memory dysfunction in L. stagnalis. The concept of in-
flammation and inflammation-mediated oxidative stress
as agents of neural dysfunction and degeneration has be-
come well-established in the context of mammalian ner-
vous systems [5,7-11,17-25,40]. However, despite their
prominence as neurobiological model systems of learn-
ing and memory, remarkably little is known about
neuroinflammatory aspects of learning and memory dys-
function in gastropods. Recent findings implicating non-
enzymatic lipid peroxidation in PLA2-dependent LTM
failure in aging L. stagnalis [6,27] led us to hypothesize
involvement of the snails’ immune system in learning
and memory dysfunction. The current results support
that hypothesis, even though many questions about the
identity, modes and loci of action of the signalling
processes involved remain to be answered. This conclu-
































Figure 8 No effect of aristolochic acid or indomethacin on
laminarin induced H2O2 release by haemocytes. Isolated
haemocytes pre-incubated for 30 minutes with either aristolochic
acid or indomethacin before being challenged with laminarin
showed a similar H2O2 production compared to haemocytes pre-
treated with vehicle only.
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transient increase in H2O2 release from circulating
haemocytes within 1-3 hrs after injection that dissipates
within 24 hrs; 2- intracoelomic injection of laminarin 1
hr before the start of behavioural conditioning induced
LTM dysfunction; 3- intracoelomic injection of lami-
narin 24 hrs before the start of behavioural conditioning
had no impact on LTM function; 4– co-administration
of laminarin with putative PLA2 inhibitor aristolochic
acid or the putative COX inhibitor indomethacin ne-
gated laminarin’s effect on LTM; 5- Neither aristolochic
acid nor indomethacin inhibited laminarin-induced
haemocyte- mediated H2O2 release; 6- intracoelomic in-
jection of laminarin did not cause obvious chemosensory
or motor deficits; 7- laminarin injection did not affect
intermediate term memory (ITM) function; 8- exposure
of isolated CNS to laminarin did not affect electrical ac-
tivity of interneuron CGC. Taken together these results
support a model in which the haemocyte’s inflammatory
response disrupts LTM formation by recruiting neuronal
PLA2-mediated processes. As will be discussed below,
such a model is consistent with our recent finding that
PLA2 plays a pivotal role in LTM impairment associated
with oxidative stress and old age in L. stagnalis [6].
Signalling mechanisms
We propose that the inflammatory response from circu-
lating haemocytes is a primary cause in laminarin’sbehavioural effects. We base this opinion on the follow-
ing evidence. First, the H2O2 release data leaves no
doubt that circulating haemocytes are among the targets
of laminarin in our experiments. Second, neither the
chemosensory response to amyl-acetate, nor the behav-
ioural response to sucrose application were affected by
laminarin 1 hr after its injection, a time point where no
measurable increase haemocyte H2O2 release had oc-
curred yet. Third, laminarin applied to isolated CNS
preparations had no effect on spontaneous spiking activ-
ity and resting membrane potential of the Cerebral
Giant Cell, one of the interneurons of the feeding circuit
that is crucial to the formation of appetitive LTM and
that receives chemosensory synaptic input and maintains
widespread synaptic connections throughout the circuit.
Although it is difficult if not impossible to test all-
inclusively for the absence of drug effects, these results
together provide quite compelling evidence that lami-
narin has no substantial direct neuronal effects in at
least the first 1-1.5 hr after treatment. Further investiga-
tions are required to assess whether, on the longer run,
laminarin may affect components of the nervous system
like perhaps the professional phagocytes known to reside
in the CNS [41].
The present results show striking parallels with a previ-
ous report that aristolochic acid corrects experimental oxi-
dative stress-induced LTM failure in L. stagnalis as well as
age-associated LTM impairment [6]. In other words, PLA2
appears to lie at the root of oxidative stress-dependent,
inflammation-induced and age-associated LTM impair-
ment paradigms in the L. stagnalis model system. We in-
terpret these parallels as evidence of a close causal relation
between these phenomena. This interpretation resonates
well with a rapidly growing literature that associates PLA2
with (neuro)inflammation, deregulation of lipid metabol-
ism, and cell-, neuronal- and cognitive dysfunction in
humans and other mammals [9,19-24].
We assume that aristolochic acid’s ability to restore
LTM impairment in the current inflammation model
reflects the drug’s actions at the level of the nervous
system. This idea arises from previous evidence demon-
strating that PLA2 inhibition with aristolochic acid re-
verses, within minutes, electrophysiological phenomena
induced by experimental oxidative stress in isolated CNS
preparations thought to contribute to LTM impairment
as well as similar phenomena in the brains isolated from
LTM impaired old snails [6,27]. The idea of a neural
locus of aristolochic acid’s restorative actions is further
supported by the present finding that the drug does not
affect laminarin-induced haemocyte H2O2 release, a re-
sult consistent with prior literature emphasizing phos-
pholipase C (PLC)/protein kinase C (PKC)-dependent
signalling pathways in this process [35,36]. Parenthetic-
ally, assuming the above reasoning is true, the question
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haemocytes and neurons arises. There is probably more
than one answer to this question. However, based on the
uncanny parallels between the experimental oxidative
stress model of LTM impairment that identifies non-
enzymatic lipid peroxidation as a probable activator of
neuronal PLA2 [6,27] and the current data, we consider
oxidizers released by activated haemocytes are plausible
candidates.
At this point it is important to recognize the import-
ance of ROS and RNS signalling in synaptic plasticity
and memory formation including the induction of LTM
in the very model system we used here [5,15,19,42-44].
Specifically, NO-signalling is particularly relevant during
the first 5 hours of LTM consolidation in the current
LTM paradigm [42,44]. Since L. stagnalis hemocyte’s re-
lease substantial amounts of NO together with H2O2
during their respiratory burst [35,36], the possibility that
haemocyte-derived NO interferes directly with critical
NO-dependent steps in appetitive LTM formation exists.
The finding that the putative COX inhibitor indometh-
acin, but not the putative LOX inhibitor NDGA, partially
reversed laminarin’s inhibition of appetitive LTM suggests
COX involvement in this process. Although this notion is
consistent with the metabolic interdependence of COX
and PLA2, this conclusion needs to be treated with some
care because, as discussed in more detail below, reserva-
tion’s about indomethacin’s COX specificity. Nevertheless,
the notion of COX involvement in inflammation-induced
learning impairment is consistent with the enzyme’s long-
standing stature as a pivotal producer of pro-inflammatory
mediators [17,18,45] and not without precedent in the con-
text of synaptic transmission and plasticity, learning and
memory formation [13-16,19,46-53]. Very little, if anything,
is known about inflammatory and/or neuro-modulatory
implications of COX activity in L. stagnalis. Considering
growing evidence implicating PLA2 and COX-metabolites
in cognitive function and dysfunction in mammals
[4,5,7,46-53], the current results, although not conclusive,
do warrant further investigation into this matter.
Haemocyte activation: in vivo immune challenge vs.
in vitro immune challenge
Our data support the conclusion that a single intracoe-
lomic injection of laminarin provokes an increase in
haemocytic H2O2 release within 1-3 hours after injection
that dissipates within 24 hrs of the injection. Whereas
these results are in general agreement with those
obtained in in vitro studies of L. stagnalis haemocytes,
they also reveal important differences [35]. Particularly,
whereas H2O2 release increases within 30 to 60 minutes
after in vitro stimulation of isolated haemocytes with
5 mg/ml laminarin, our results indicate that the same
may take up to three hours when laminarin is injectedinto the animal’s body cavity. Considering the much
more complex biological and pharmacokinetic condi-
tions prevailing in the whole animal, a somewhat slower
and smaller in vivo response does not seem to be out of
the ordinary. Most importantly, although we cannot pin-
point the exact time course of the response, our data do
support the notion that the impact of laminarin injection
on haemocyte H2O2 release is gone by the time LTM
tests are performed 24 hrs after training.
Limitations: alternative targets of laminarin and drug
specificity?
As any other study relying on pharmacological interven-
tions, our results might be affected by non-specific
actions of the drugs we used. Aristolochic acid has a
long track record as broad spectrum PLA2 inhibitor
[54-56]. Other than an extensive literature on the com-
pound’s genotoxic effects that are associated with its
ability to form aristolactam-DNA adducts [57,58], we
are not aware of reports of non-specific activities. It
seems unlikely that DNA-adduction is a factor of im-
portance in the present study. An observation strength-
ening our believe in aristolochic acid’s relative specificity
is the finding that the compound does not interfere with
laminarin’s ability to activate haemocytes, a process
that involves a major phospholipid-dependent signalling
component in the form of protein kinase C- (PKC),
phospholipase C- (PLC), extracellular signal-regulated
kinase- (ERK) and MAPK/ERK kinase (MEK)-dependent
signalling cascade [35]. Moreover, no effect of aristolochic
acid on electrophysiological, behavioural and biochem-
ical facets were observed in L. stagnalis without any
form of pro-oxidant present [6]. While we have no compel-
ling reason to suspect aristolochic acid’s pharmacological
activities, indomethacin warrants more extensive scru-
tiny. For instance, like other NSAIDs, indomethacin
may modify the activity of various serine/threonine
kinases [59,60]. However, electrophysiological studies
on L. stagnalis neurons revealed no evidence of indo-
methacin effects on PKC nor protein kinase A (PKA)
signalling at the concentrations used here [61]. More-
over, we show that indomethacin does not affect lami-
narin induced H2O2 release from haemocytes, which as
noted before, is a PKC-dependent process. Thus, it
seems unlikely that the effects of indomethacin reported
here are due to interference with PKA and/or PKC
signalling. However, several reports indicate that indo-
methacin, in addition to its ability to inhibit COX, can
inhibit several types of PLA2 enzymes [55,62-64]. No in-
formation is available about the type of PLA2 underlying
the current observations. Thus we cannot exclude the
possibility that indomethacin’s effects reported here are
in part due to the inhibition of PLA2. However, that
uncertainty does not in any way invalidate our central
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tion induces PLA2-dependent LTM dysfunction.
Differential susceptibility of ITM and LTM to systemic
immune challenge
Our results show that non-aversive appetitive ITM in
contrast to its LTM counterpart is not significantly
compromised by systemic injection of laminarin. There
are a number of noteworthy observations to make from
this finding. First, it provides additional evidence that rela-
tively short term exposure to laminarin itself does not
compromise the neural systems and processes involved in
the detection and execution of chemosensory-induced
feeding responses. Second, it points towards independence
of the neural substrates ITM and LTM and as such reiter-
ates recent evidence by Marra et al. indicates that non-
aversive appetitive ITM and LTM formation in this model
follows a parallel rather than serial causal pathway [65].
Third, the current evidence that LTM is more sensitive to
disruption of immune-related processes than ITM takes
on a particularly intriguing perspective in view of a grow-
ing body of literature associating (neuro)inflammation
with age-associated cognitive and neurological dysfunction
and our own work showing LTM but not ITM to be im-
paired in old L. stagnalis in both learning and memory
paradigms we use in our research [6,26].
Conclusion
In this study we provide evidence for a role of the innate
immune system in learning and memory impairment in
the snail L. stagnalis. Specifically, our results indicate
that provocation of the immune system induces a PLA2-
dependent form of LTM dysfunction resembling the
memory impairment associated with experimental (lipid
per-)oxidative stress and old age in this model system.
The results emphasize the significance of membrane lipid
biology and enzymes of the PLA2 family in dysfunction of
the nervous system of this invertebrate model system and
underwrite the fast growing perception of these processes
as a fundamental and evolutionary conserved dimension
of immune- and age-associated changes in neural- and
cognitive failure. As such, L. stagnalis provides an excel-
lent model system for detailed fundamental investigations




Snails were bred and raised under constant conditions
as previously described [6,26,27,32,66]. Briefly, snails
were raised in house under strictly controlled ambient
conditions (light:dark 12:12, ambient temperature
18-19°C, pH 7.8-7.9). Water used in the facility was
sourced from a reverse osmosis system and recondi-tioned to a conductivity of ~450 Ω.cm through the
addition of Instant Ocean salts at 1 g/US Gallon (i.e.,
artificial pond water; Aquarium Systems USA). Calcium
concentration was kept at saturation level (>60 mg/L as
CaCO3) through the addition of calcium carbonate (light
powder; EMD analytics, Gibbstown, New Jersey) to the
tanks. In addition, snails had continuous access to steril-
ized cuttlefish (Sepia officinalis) bone (2–3 per tank).
Snails were fed ad libitum with a standard diet
consisting of Romaine lettuce and Aquamax-carniverous
Grower 600 trout pellets (Purina Mills LLC, St. Louis,
Missouri).
Health and survival characteristics of the populations
were continuously monitored and evaluated using previ-
ously established methods based on the Weibull failure
model [67,68]. Experimental snails were taken at random
from populations with healthy demographic parameters
with survival percentages >95% and chronological ages
ranging between 5-7 months of age at the time of
sampling (note: in our experimental populations this
amounts to young sexually mature snails). Snail use and
care procedures conformed to rules of the University of
Calgary Animal Care and Use Policy which adheres to
the guidelines, policies and standards of the Canadian
Council on Animal Care (CCAC), the Canadian Associ-
ation of Laboratory Animal Medicine (CALAM), stan-
dards of Veterinary Care, and the Alberta Veterinary
Association (AVMA) professional codes and standards.
Behavioural training and testing procedures
Preparation
Behavioural conditioning was done using a non-aversive
appetitive classical conditioning protocol (modified from
[26]; see also [32]). Snails were sampled at random and
marked for identification purposes with indelible marker.
Food was withheld starting 48 hrs prior to the first pre-
training test and for the remainder of the training and
post-training testing.
Testing procedures
On day 1, prior to behavioural conditioning, snails were
individually tested for their natural response to the ad-
ministration of pond water, the disturbance stimulus
(DS), as well as the conditional stimulus (CS) n-amyl
acetate (“Pre-training test”; see also [32]). Tests were
performed using 100-ml translucent polystyrene beakers
(4.5 cm diameter), filled with 80 ml of water taken from
the snail’s home tank. After transfer into the beakers, the
snails were allowed to acclimatize for 15 min before test-
ing commenced. Testing involved counting the number
of rasps over two consecutive periods of 2 min, the first
period starting with gentle administration of the DS (10
ml artificial pond water), the second period starting with
the administration of the CS (10 ml n-amyl acetate
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vation, the test beakers were elevated on translucent
plastic stands surrounded by mirrors. A test response
was calculated by taking the difference between the
number of rasps counted during the second period
minus the number counted during the first period (i.e.,
ΔRasp = rasps after CS – rasps after DS). To correct for
both differences in background rasping activity and po-
tential application artefacts, the pre-training tests were
performed in duplicate with >1 hr interval, and behav-
ioural responses were calculated as the average of both
ΔRasp (i.e., ΔRasppre-test = average ΔRasppre-test1 and
ΔRasppre-test2). After completion of a test, snails were
gently rinsed with clean pond water and returned to
their home tanks. Following identical procedures as
described for the pre-testing above, a single post-
training test was performed 1-2 hrs after training to
asses intermediate term memory (ITM) or on day 3 (i.e.,
24 hrs after training) to asses long-term memory (LTM)
performance.
Training procedure
Snails were trained in a single day, multi-trial forward-
delay conditioning format (modified from [26]; see also
[32]). Sucrose (final concentration of 0.4% wt/vol) served
as the unconditioned stimulus (UCS) and n-amyl acetate
(4 ppm final concentration) as the conditioned stimulus
(CS). To control for potential behavioural effects of fluid
addition, a disturbance control in which the UCS was
paired with the DS (i.e., pond water) was implemented.
Snails were randomly assigned to either the CS–UCS
(“conditioned”) or the CS–DS (unconditioned “control”)
group and trained “en masse”. Training was performed
in 1-L polypropylene beakers containing 480 ml clean
artificial pond water. After transfer into the training bea-
kers, the snails were allowed to acclimatize for 60 min.
Both “control” and “conditioned” groups received 120
ml of the CS solution, followed 15 s later by 120 ml of
the UCS (“conditioned” group) or 120 ml of the DS
(“control” group). After 2 min, the beakers containing
the snails were drained and gently rinsed with clean
pond water and the snails were readied for their next
training trial by re-placing them in the 1-L polypropyl-
ene beakers holding 480 ml clean artificial pond water.
After 11 min and 45 sec the training procedure was re-
peated. Snails received a total of 5 training procedures
on a single day before being returned to their “home”
tank. The snails were at all times fully submerged during
training and testing. Care was taken to ensure that pre-
training tests, training and post-training tests com-
menced at the same time of day for each group and
training and testing always occurred in the same loca-
tion. “Conditioned” and “control” snails were always
tested and trained concurrently.Sucrose induced feeding behaviour in naïve animals
To assess whether laminarin induces chemosensory and/
or motor deficiency, naïve snails injected with either
laminarin or vehicle were tested for their feeding re-
sponse upon sucrose application (see also [32]). Tests
were performed using 100-ml translucent polystyrene
beakers (4.5 cm diameter), filled with 80 mL of water
taken from the snail’s home tank. After transfer into
the beakers, the snails were allowed to acclimatize for
15 min before testing commenced. Testing involved
counting the number of rasps over three consecutive pe-
riods of 2 min, the second period starting with gentle
administration of artificial pond water (10 ml) a disturb-
ance stimulus (DS), the third period starting with the
administration of sucrose solution (0.4% w/v final con-
centration). The disturbance response was calculated by
taking the difference between the number of rasps
counted during the second period minus the number
counted during the first period (i.e., ΔRasp disturbance =
rasps after DS – rasps after pond water). The sucrose re-
sponse was calculated by taking the difference between
the number of rasps counted during the third period
minus the number counted during the second period (i.e.,
ΔRasp sucrose = rasps after sucrose – rasps after DS).
Electrophysiology
For electrophysiological assessments, snails were de-
shelled using curved forceps and subsequently anaesthe-
tized in a 25% Listerine solution. All dissections and
experiments were carried out in a hydroxyethylpipe-
razine ethanesulphonic acid (HEPES) -buffered saline
(HBS) composed of (in mM) 51.3 NaCl, 1.7 KCl, 4.1
CaCl2, 1.5 MgCl2 and 10 HEPES (pH 7.9).
Extracellular recordings
Extracellular recordings of lip sensory neurons were
made from the superior lip nerve in a semi-intact prep-
aration by means of a suction electrodes as described by
Watson et al., [32]. Briefly, the central nervous system
(CNS) was exposed by means of a small dorsal incision
in the midline of the head region. The head of the snail
containing the lips, tentacles and buccal mass, plus the
CNS was carefully dissected from the rest of the body.
Subsequently the right superior lip nerve was cut as
close to the CNS as possible. The remaining peripheral
nerves were cut as distally as possible and the CNS was
discarded. The semi-intact preparation was pinned down
in a Sylgard coated dish, and the superior lip nerve was
drawn into a glass microelectrode with a diameter just
large enough to accommodate the nerve. A perfusion
system was used to continuous apply saline or n-amyl
acetate (4 ppm) with the outflow placed close to the lip/
mouth region. Extracellular signals were amplified using
a DAM-80 differential amplifier (World Precision
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Hz and digitized at 5 kHz sampling rate using a Digidata
1322A AD/DA converter under the control of Axoscope
9 software (both Axon Instruments, Union City, CA).
Recordings were analyzed offline using template-
matching waveform recognition software (Spike2, ver-
sion 4.02a, Cambridge, England). Template selection
criteria were set to ignore waveforms that occurred less
frequently than 1 in 50 events. From these data overall
peristimulus histograms were generated with bin sizes of
30 seconds.Intracellular recordings
CNSs were dissected as described earlier [69]. Isolated
CNSs were pinned down in an elastomer covered re-
cording chamber filled with HBS. To provide access to
the Cerebral Giant Cells (CGCs), the outer layer of con-
nective tissue surrounding the cerebral ganglia were re-
moved with fine forceps without the use of proteolytic
enzymes [69,70]. Intracellular recordings of the CGCs
were done by means of microelectrode recording tech-
niques with the use of either Axoclamp 2A or Axoclamp
2B, (Axon Instruments, Burlingame, CA). Amplifier out-
put was filtered at 1 kHz and digitized at 5 kHz using a
Digidata 1322A AD/DA converter (Axon Instruments,
Burlingame, CA). Data acquisition was carried out with
Axoscope sampling software (version 9.0, Axon Instru-
ments) and subsequently analyzed using Clampfit
software (version 9.0 Axon Instruments). Borisilicate
glass electrodes (TW150F, World Precision Instruments,
Sarasota, FL) were filled with a solution of 0.5 M potas-
sium acetate (CH3COOK) and 0.01 M potassium chlor-
ide (KCl) saline. DC resistance of the electrodes ranged
between 25-55 MΩ.Drug injections
Drug or vehicle-only treatments were delivered by
means of intracoelomic injection into the snail in a man-
ner avoiding whole-body withdrawal responses and
voiding of haemolymph (see also [6,32]). Drugs were
dissolved in sterilized ultrapure water or DMSO. Using
body weight measurements injected amounts of drugs
were calculated to achieve the following approximate
concentrations of drugs in the snails’ haemolymph: 10
μM of the PLA2 inhibitor aristolochic acid, 5 mg/ml of
laminarin, 10 μM of indomethacin and 10 μM of nordi-
hydroguaiaretic acid (NDGA). Haemolymph DMSO
concentrations never exceeded 0.02%. As control, snails
were injected with equivalent volumes vehicle only
(vehicle control). Unless indicated otherwise, all injec-
tions were given 1 hour prior to the start of the first
training session. All solutions were injected through the
foot directly into the haemocoel with a microlitersyringe and a 25G needle. Snails were behaving normally
within 1-2 minutes after injection.
Haemocyte respiratory burst assays
In vivo
To quantify the effect of various in vivo treatments on
haemocyte activity status, 200-300 μl samples of haemo-
lymph per snail were taken 0.5 hr, 1 hr, 3 hrs or 24 hrs
after injection using a non-invasive technique described
by Sminia [71]. For each treatment condition haemolymph
sampled from at least 3 snails was pooled, diluted in fil-
tered sterilized HBS (1:2, HBS:haemolymph) and placed
on ice (see also [36]). Hydrogen peroxide release by iso-
lated haemocytes was measured using an Amplex Red
assay according to the suppliers instructions (Invitrogen,
Burlington, ON). Briefly, diluted haemolymph was added
to a 96-well Nunc culture plate (50 μl per well) containing
150 μl Amplex red reaction solution (50 μM Amplex Red;
reagent; 0.1 U/ml horseradish peroxidase). Immediately,
fluorescence intensity was measured (544 nm excitation,
590 nm emission) using a Spectromax 2Me multidetection
microplate reader (Molecular Devices, Sunnyvale, CA).
Three independent experiments with each 3-4 replicates/
condition were performed.
In vitro
The inhibitory effect of various compounds on haemo-
cyte H2O2 production in vitro was determined according
to a procedure described by Lacchini et al. [35]. Briefly
haemolymph samples of 20 snails were collected, pooled,
diluted in filter sterilized HBS (1:2, HBS:haemolymph)
and stored on ice. Diluted haemolymph was added to a
96-well Nunc culture plate (200 μl per well). After a 30
minutes equilibration period, aristolichic acid (10 μM),
indomethacin (10 μM), or vehicle only were added to
the samples. After an additional 30 minutes, 100 μl
Amplex red reaction solution (see above) plus laminarin
(5 mg/ml) was added to each sample and incubated for
an additional 30 minutes. Fluorescence intensity was
measured as described above.
Solutions and chemical suppliers
With the exception of the Amplex red hydrogen pero-
xide/peroxidase assay kit purchased from Invitrogen
(Burlington, ON) and indomethacin obtained from
Calbiochem (San Diego, CA), all chemicals were obtained
from Sigma Aldrich (St. Louis, MO).
Statistical analysis
Behavioural data was analyzed by means of fully-
factorial or repeated measure ANOVA. Explicit hypoth-
eses were tested using planned comparisons. Haemocyte
hydrogen peroxide release data was analyzed by means
of repeated measures ANOVA. Compliance with
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prior to ANOVA using both graphical (probability plots
applied to raw data and residuals) and analytical tech-
niques (Levene’s test, Kolmogorov-Smirnov one-sample
test for normality and F-max test). Throughout the text,
average and data dispersion are expressed as arithmetic
means and standard error of the mean (SEM). Figures
were constructed using Graphpad Prism version 4.03
(Graphpad Software Inc., La Jolla, CA).
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